Go to the page content

Help desk · terms behind the offer

Medicine, money and the missing answers

An offer can sound clear while leaving the important parts unnamed. Begin by naming the product and asking why it has been suggested.

Is peptide treatment real medicine?

Semaglutide and tirzepatide are ingredients in approved medicines for weight loss or type 2 diabetes, a blood-sugar illness. FDA records were checked on September 26, 2026.

Semaglutide is the working ingredient in Ozempic, used for type 2 diabetes.

Wegovy also contains semaglutide and is used for weight loss.

Tirzepatide is the working ingredient in Mounjaro, used for type 2 diabetes.

Zepbound also contains tirzepatide and is used for weight loss.

FDA approval is for a named medicine and what it is used to treat. It does not cover every offer called peptide treatment.

Ask: “Which product is this, and why is it being considered for my concern?”

According to FDA’s approval records

Check the product, not the treatment label

Does “made for me” mean approved?

Compounded medicines lack FDA approval, according to FDA’s position as of September 26, 2026.

FDA does not review these medicines for safety, quality or how well they work before sale.

A medicine made for one person can meet a need that an approved, ready-made medicine cannot meet. Making medicine this way can be legal.

Ask: “What need makes a prepared medicine necessary in my case?”

According to FDA’s compounding guidance

The limits on making copies

As of September 26, 2026, ordinary pharmacies cannot regularly make near-copies of medicines already sold ready-made.

An exception to the copy rule applies when a medicine is changed for one patient identified by name.

For example, a pharmacy might leave out a dye that causes an allergic reaction for that patient.

The prescriber must decide that this change makes an important difference in the care of that particular patient.

A cheaper price alone does not allow a pharmacy to make a copy under this rule.

What offers need a pause?

Retatrutide and cagrilintide are names of unapproved drug ingredients.

Under federal law, FDA says medicines prepared to order for patients cannot contain retatrutide or cagrilintide, as of September 26, 2026.

No FDA-approved medicine contains either ingredient. Neither ingredient has been shown to be safe and effective for treating any condition.

FDA also urges people to avoid products labelled for research that are offered for human use; their quality is unknown.

According to FDA’s unapproved-drug guidance

What a research label means for treatment

What might it cost?

Ask for the total cost of the plan, including every separate charge and the price after any discount ends.

On September 26, 2026, the government’s price page listed these cash terms for semaglutide (Ozempic) pens.
Introductory price
The price is $199 per month for each of the first two monthly supplies. Eligible strengths are 0.25 mg and 0.5 mg.
Price after the offer
$349 per month applies to strengths of 0.25 mg, 0.5 mg and 1 mg; the 2 mg strength costs $499 per month.

The introductory terms cover new self-pay patients who are US residents aged 18 or older.

December 31, 2026, is the last day of the introductory offer.

A deductible is the amount paid before an insurance plan starts paying its share.

Under this offer, insurance cannot repay what you spend in cash. Those payments cannot count toward your deductible.

This is a medicine-only example, not a total for care in Peoria. Ask for a written quote for the actual plan.

According to the government’s cash-price terms

Read the offer limits as well as the price

What can Medicare cover?

For Medicare to pay for a medicine, the reason for treatment matters. Ask the insurer to confirm payment for the exact medicine and use.

As of September 26, 2026, certain medicines may be paid for by Medicare when used for something other than weight loss, such as diabetes.

The medicine must be on the plan’s list of drugs it pays for. The plan may also need to agree in advance before it will pay.

As of September 26, 2026, Medicare also has a temporary weight-loss drug program with rules about who can join.

That program is scheduled to end on December 31, 2027.

Ask the insurer: “Will my plan pay for this exact medicine for the illness I have, and what would I pay?”

According to Medicare coverage guidance

Ask the plan about the named use

When is it time to step back?

Federal law, as of September 26, 2026, requires a valid prescription when supplying prescription medicine.

FDA’s checklist also flags damaged packaging, unclear pharmacy details and no doctor available for questions afterward.

A very low price can be a warning when other checks fail; price alone does not establish a problem.

According to FDA’s warning-sign checklist

Look at the process as well as the price

When help cannot wait

MedlinePlus names breathing or swallowing trouble and a swollen face or tongue as signs of a severe allergic reaction.

If symptoms are severe, get emergency help. Call 911 or go to the nearest emergency room.

According to MedlinePlus emergency guidance

Urgent help for a severe allergic reaction

Take the open questions to the visit

Ask for an explanation in words that make sense to you.

Return to the Peoria care checklist